Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or...

Area of Science:

• Cardiology
• Medical Devices
• Public Health

Background:

• Implantable cardioverter defibrillators (ICDs) are crucial for primary prevention of sudden cardiac death.
• Accurate mortality risk assessment is vital for optimizing ICD implantation decisions.
• Differentiating risk factors in ischaemic versus non-ischaemic heart disease is essential.

Purpose of the Study:

• To evaluate survival rates in primary prevention ICD patients.
• To develop a baseline mortality risk score for these patients.
• To compare mortality risk factors between ischaemic and non-ischaemic heart disease.

Main Methods:

• Retrospective analysis of 1036 patients who received an ICD for primary prevention.
• Data collected from Leiden University Medical Center since 1996.
• Follow-up duration of 873 days to assess mortality outcomes.

Main Results:

• Overall mortality was 13% (138 patients) during follow-up.
• Similar survival observed between non-ischaemic and ischaemic heart disease groups.
• A baseline risk score effectively stratified patients into low, intermediate, and high mortality risk categories.

Conclusions:

• An easily applicable baseline risk score aids in tailored mortality risk estimation for ICD patients.
• The score assists clinicians in daily practice for personalized patient management.
• Risk stratification is crucial for optimizing outcomes in primary prevention ICD recipients.